Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)—results from the ILUVIT study

被引:0
|
作者
Svenja K. Deuchler
Ralf Schubert
Pankaj Singh
Adonis Chedid
Ninel Kenikstul
Julia Scott
Thomas Kohnen
Hanns Ackermann
Frank Koch
机构
[1] Augenzentrum Frankfurt,Department of Ophthalmology
[2] Goethe University Hospital,Pneumological
[3] Goethe University Hospital,Immunological Laboratory
[4] Goethe University Hospital,Institute of Biostatistics
关键词
Cytokines; Diabetic macular edema; Diabetic retinopathy; Fluocinolone acetonide; Growth factors; Inflammatory markers;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2537 / 2547
页数:10
相关论文
共 50 条
  • [41] Early treatment with the 0.19 mg fluocinolone acetonide implant is associated with improved functional and anatomical outcomes in patients with persistent or recurrent diabetic macular edema
    Pessoa, Bernardete
    Silva, Nisa
    Marta, Ana
    Coelho, Joao
    Beirao, Melo
    Meireles, Angelina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [42] 6-year outcomes of the United Kingdom Medisoft® audit study following treatment with the ILUVIEN® (fluocinolone acetonide) implant in patients with diabetic macular edema.
    Mushtaq, Bushra
    Bailey, Clare C.
    Chakravarthy, Usha
    Lotery, Andrew J.
    Talks, James
    Menon, Geeta
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [43] A New Approach for Diabetic Macular Edema Treatment: Review of Clinical Practice Results with 0.19 mg Fluocinolone Acetonide Intravitreal Implant Including Vitrectomized Eyes
    Estebainha, Raquel
    Goldhardt, Raquel
    Falcao, Manuel
    CURRENT OPHTHALMOLOGY REPORTS, 2020, 8 (01) : 1 - 10
  • [44] The use of fluocinolone acetonide implant(ILUVIEN) in patients with diabetic macular edema(DME) previously treated with dexamethasone intravitreal implant(OZURDEX) - Efficacy and safety outcomes from clinical practice in Glasgow, Scotland
    Rajasekaran, Sridevi
    Mulla, Umaima
    Drummond, Suzannah
    Gavin, Mike
    Wykes, William
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [45] A New Approach for Diabetic Macular Edema Treatment: Review of Clinical Practice Results with 0.19 mg Fluocinolone Acetonide Intravitreal Implant Including Vitrectomized Eyes
    Raquel Estebainha
    Raquel Goldhardt
    Manuel Falcão
    Current Ophthalmology Reports, 2020, 8 : 1 - 10
  • [46] REAL-LIFE EFFICACY WITH ILUVIEN® (FLUOCINOLONE ACETONIDE [FAC]) IN DIABETIC MACULAR EDEMA (DME) PATIENTS IN 4 PORTUGUESE OPTHALMOLOGY UNITS
    Meireles, Angelina
    Pessoa, Bernardete
    Coelho, Joao
    Teixeira, Carla
    Falcao, Manuel Alberto
    Goncalves, Rita
    Silva, Marta Ines
    Castro e Sousa, Joao Paulo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [47] Safety and efficacy of fluocinolone acetonide intravitreal implant (Iluvien®) in patients with chronic diabetic macular edema in a real-life setting
    Santos, Monica
    Campos, Antonio
    Neves, Arminda
    Alfaiate, Pedro
    Pereira, Joana
    Castro e Sousa, Joao Paulo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [48] Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients
    Anne Studsgaard
    Kåre Ørts Clemmensen
    Mette Slot Nielsen
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 1633 - 1639
  • [49] BETTER BASELINE VISION LEADS TO BETTER OUTCOMES AFTER THE 0.19-mg FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT IN DIABETIC MACULAR EDEMA
    Gonzalez, Victor
    Luo, Caesar
    Almeida, David R. p.
    Cutino, Antonio
    Coughlin, Brandon
    Kasper, Jonathan F.
    Kiernan, Daniel
    PALADIN Study Grp
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2023, 43 (08): : 1301 - 1307
  • [50] Intravitreal fluocinolone acetonide 0.19 mg (Iluvien (R)) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients
    Studsgaard, Anne
    Clemmensen, Kare Orts
    Nielsen, Mette Slot
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (05) : 1633 - 1639